Literature DB >> 10027521

Early- and late-stage Kaposi's sarcoma lesions exhibit similar proliferation fraction.

F De Thier1, T Simonart, P Hermans, J André, J P Van Vooren, J C Noel.   

Abstract

There are few studies on the proliferative activity of cells in Kaposi's sarcoma. It remains unclear whether the different progressive histologic stages of Kaposi's sarcoma correlate with the proliferative activity of the tumor. To clarify this issue, we studied the Ki-67 proliferation index in 40 specimens of acquired immune deficiency syndrome-related Kaposi's sarcoma in correlation with the histologic stage of the lesions. The mean proliferation index in our combined material was rather low (8%, range 1-20%) and there was no significant difference among the different stages of the disease. Contrary to a common and probably misleading concept, our results suggest that the histologic progression of the Kaposi's sarcoma is not related to an increase of the proliferative compartment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027521     DOI: 10.1097/00000372-199902000-00005

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

1.  Human herpesvirus 8 viral FLICE-inhibitory protein retards cell proliferation via downregulation of Id2 and Id3 expression.

Authors:  Yi-Fen Wang; Lin-Yu Wang; Yi-Ling Li; Huey-Wen Shyu; Yee-Hsuan Chiou; Miao-Chen Chou; Kuan-Hua Lin; Ming-Hong Tai; Chang-Yu Chen
Journal:  Mol Cell Biochem       Date:  2010-05-29       Impact factor: 3.396

2.  Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.

Authors:  Mathias Thurau; Gaby Marquardt; Nathalie Gonin-Laurent; Kristina Weinländer; Elisabeth Naschberger; Ramona Jochmann; Khaled R Alkharsah; Thomas F Schulz; Margot Thome; Frank Neipel; Michael Stürzl
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

3.  Disseminated cutaneous Kaposi sarcoma in a patient receiving triptolide/tripdiolide for rheumatoid arthritis.

Authors:  Alicja E Grzegorzewska; Dorota Frankiewicz; Danuta Bręborowicz; Irena Matławska; Wiesława Bylka
Journal:  Med Sci Monit       Date:  2012-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.